V Wealth Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

V Wealth Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33,615	Closed	-$53K	–	418
2022 Q3	$53K	Buy	+33,615	New	+$76.3K	0.01%	369

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

V Wealth Advisors's SRNE Position: Q4 2022 in Review

V Wealth Advisors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 33,615 shares — an estimated $53K sold.

V Wealth Advisors first reported a position in SRNE in Q3 2022 and held it in 1 quarter. The position peaked at $53K in Q3 2022. 221 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

V Wealth Advisors reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
V Wealth Advisors sold 33,615 Sorrento Therapeutics, Inc. shares in Q4 2022, an estimated $53K.
V Wealth Advisors first reported a position in Sorrento Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
V Wealth Advisors's Sorrento Therapeutics, Inc. position peaked at $53K in Q3 2022.
221 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on V Wealth Advisors's 13F filing for Q4 2022, filed 20 Jan 2023.